Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Plos One|September 24, 2008
Characterization of parameters required for effective use of tamoxifen-regulated recombinationBen Buelow, Andrew M Scharenberg
The Journal of Biological Chemistry|July 5, 2008
The Poly(ADP-ribose) polymerase PARP-1 is required for oxidative stress-induced TRPM2 activation in lymphocytesBen Buelow, Yumei Song, Andrew M Scharenberg
Plos One|July 31, 2009
Structure/function analysis of PARP-1 in oxidative and nitrosative stress-induced monomeric ADPR formationBen Buelow, Burak Uzunparmak, Marcia Paddock, et al.
Journal of Biomolecular Screening|December 7, 2007
Development and validation of a cell-based high-throughput screening assay for TRPM2 channel modulatorsYumei Song, Ben Buelow, Anne-Laure Perraud, et al.
The American Journal of Forensic Medicine and Pathology|November 23, 2011
Peliosis hepatis presenting as liver rupture in a vulnerable adult: a case reportBen Buelow, Jeffrey Otjen, Annette P Sabath, et al.
Frontiers in Immunology|October 29, 2025
Inhibition of CD38 enzyme activity on engrafted human immune cells enhances NAD+ metabolism and inhibits inflammation in an in-vivo model of xeno-GvHDGhenima Ahmil-Boiteau, Pranjali Dalvi, Kevin Dang, et al.
Ejhaem|July 18, 2022
Ex vivo efficacy of BCMA-bispecific antibody TNB-383B in relapsed/refractory multiple myelomaDavid M Foureau, Manisha Bhutani, Myra Robinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2022
A Phase I First-in-Human Study of ABBV-383, a B-Cell Maturation Antigen × CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple MyelomaAnita D'Souza, Nina Shah, Cesar Rodriguez, et al.
Mabs|January 31, 2019
Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodiesNathan D Trinklein, Duy Pham, Ute Schellenberger, et al.
Journal for Immunotherapy of Cancer|June 5, 2021
Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine releaseKevin Dang, Giulia Castello, Starlynn C Clarke, et al.
Pageof 2